FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1350511000001103: Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24409301000001111 Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
24409401000001115 Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Is a Spironolactone 50mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Is pack of Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) false Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Has active ingredient Spironolactone false Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Has AMP Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Has specific active ingredient Spironolactone true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start